Adam Barker

Adam Barker, PhD

Languages spoken: English

  • Dr. Barker is interested in mycobacterial pathogenesis and improving early diagnosis of emerging pathogens in this area. He wants to lead the field in mass spectrometry in the clinical microbiology laboratory. In particular, rapid identification and classification of difficult pathogens for a fraction of the cost.

    Dr. Barker’s lab researches Mycobacterium abscessus and Pseudomonas aeruginosa pathogenesis. He is interested in identifying unknown, unclassified virulence factors that contribute to pathogenesis. He also is interested in the biochemistry of gamma interferon inducible lysosomal thiol reductase (GILT) in collaboration Dr. Peter Jensen.

    Specialties

    • Pathology, Clinical

  • Dr. Barker is interested in mycobacterial pathogenesis and improving early diagnosis of emerging pathogens in this area. He wants to lead the field in mass spectrometry in the clinical microbiology laboratory. In particular, rapid identification and classification of difficult pathogens for a fraction of the cost.

    Dr. Barker’s lab researches Mycobacterium abscessus and Pseudomonas aeruginosa pathogenesis. He is interested in identifying unknown, unclassified virulence factors that contribute to pathogenesis. He also is interested in the biochemistry of gamma interferon inducible lysosomal thiol reductase (GILT) in collaboration Dr. Peter Jensen.

    Board Certification and Academic Information

    Academic Departments Pathology -Primary

    Education history

    Fellowship Medical Microbiology - University of Utah, Pathology Department Fellow
    Harvard Medical School, Department of Microbiology and Molecular Genetics Fellow
    Doctoral Training University of Colorado Health Sciences Center, Microbiology and Immunology Department Ph.D.
    Colorado State University, Department of Microbiology B.S.